Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 141


FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.

Tahari AK, Alluri KC, Quon H, Koch W, Wahl RL, Subramaniam RM.

Clin Nucl Med. 2014 Mar;39(3):225-31. doi: 10.1097/RLU.0000000000000255.


Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?

Kendi AT, Magliocca K, Corey A, Nickleach DC, Galt J, Higgins K, Beitler JJ, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM.

Clin Nucl Med. 2015 Mar;40(3):e196-200. doi: 10.1097/RLU.0000000000000691.


Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.

Alluri KC, Tahari AK, Wahl RL, Koch W, Chung CH, Subramaniam RM.

AJR Am J Roentgenol. 2014 Oct;203(4):897-903. doi: 10.2214/AJR.14.12497.


18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.

Huang YT, Ravi Kumar AS, Bhuta S.

Nucl Med Commun. 2015 Jan;36(1):16-20. doi: 10.1097/MNM.0000000000000208.


Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.

Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC.

Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1673-84. doi: 10.1007/s00259-012-2186-9. Epub 2012 Aug 2.


Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.

Chan JY, Sanguineti G, Richmon JD, Marur S, Gourin CG, Koch W, Chung CH, Quon H, Bishop JA, Aygun N, Agrawal N.

Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1040-6. doi: 10.1001/jamaoto.2013.607.


Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

Tang C, Murphy JD, Khong B, La TH, Kong C, Fischbein NJ, Colevas AD, Iagaru AH, Graves EE, Loo BW Jr, Le QT.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1514-20. doi: 10.1016/j.ijrobp.2011.10.023. Epub 2012 Jan 21.


Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.

Joo YH, Yoo IeR, Cho KJ, Park JO, Nam IC, Kim MS.

Head Neck. 2014 Mar;36(3):323-7. doi: 10.1002/hed.23296. Epub 2013 Jun 1.


Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.

Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa S, Yamashita Y.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):377-82. Epub 2007 Feb 22.


Predictive accuracy of first post-treatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma.

Koshkareva Y, Branstetter BF 4th, Gaughan JP, Ferris RL.

Laryngoscope. 2014 Aug;124(8):1843-7. doi: 10.1002/lary.24617. Epub 2014 Mar 11.


18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H.

J Nucl Med. 2012 Oct;53(10):1506-13. doi: 10.2967/jnumed.111.101402. Epub 2012 Aug 14.


PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.

Subramaniam RM, Alluri KC, Tahari AK, Aygun N, Quon H.

J Nucl Med. 2014 Mar;55(3):431-8. doi: 10.2967/jnumed.113.125542. Epub 2014 Jan 9. Review.


Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis.

Cantrell SC, Peck BW, Li G, Wei Q, Sturgis EM, Ginsberg LE.

AJNR Am J Neuroradiol. 2013 Oct;34(10):2005-9. doi: 10.3174/ajnr.A3524. Epub 2013 May 9.


Interaction of quantitative 18 F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, Braakhuis BJ, Brakenhoff RH, Leemans CR, Hoekstra OS, de Bree R.

Head Neck. 2014 Oct 29. doi: 10.1002/hed.23920. [Epub ahead of print]


FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.

Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H, Subramaniam RM.

AJR Am J Roentgenol. 2014 Aug;203(2):W139-45. doi: 10.2214/AJR.13.11654.


Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.

Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC.

J Nucl Med. 2013 Oct;54(10):1703-9. doi: 10.2967/jnumed.112.119289. Epub 2013 Sep 16.


Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.

Vainshtein JM, Spector ME, Stenmark MH, Bradford CR, Wolf GT, Worden FP, Chepeha DB, McHugh JB, Carey T, Wong KK, Eisbruch A.

Oral Oncol. 2014 Mar;50(3):234-9. doi: 10.1016/j.oraloncology.2013.12.003. Epub 2013 Dec 31.


Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies.

Morani AC, Eisbruch A, Carey TE, Hauff SJ, Walline HM, Mukherji SK.

J Comput Assist Tomogr. 2013 May-Jun;37(3):343-5. doi: 10.1097/RCT.0b013e318282d7c3.


18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.

Roh JL, Park JP, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Radiology. 2014 Apr;271(1):153-61. doi: 10.1148/radiol.13131470. Epub 2013 Nov 23.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk